Brings complementary features in India to address patient populations most at risk Genzyme Corp.

Brings complementary features in India to address patient populations most at risk Genzyme Corp. , a worldwide leader in biotechnology, and Medications for Malaria Venture , a not-for-profit virtual research and development organization focused on reducing the responsibility of malaria, announced a fresh collaboration with India’s Advinus Therapeutics Ltd http://zithromax500.net/azithromycin.htm . The collaboration seeks to build up new, improved remedies for specific patient groups most at risk for malaria, an often fatal infectious disease of developing countries, affecting pregnant women and infants particularly.